ArticleReviews in cardiovascular medicine2023

The Prognostic Value of Biomarkers in Non-ST-Elevation Acute Coronary Syndrome Patients that are Treated by an Early Invasive Strategy: Insights from the OPTIMA-2 Trial.

Nick D Fagel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.